Acute diarrhea resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 27: | Line 27: | ||
==Management== | ==Management== | ||
{{familytree/start |summary=Acute Diarrhea Algorithm}} | {{familytree/start |summary=Acute Diarrhea Algorithm}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | A01 = Adults with acute diarrhea (<4 | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | A01 | | A01 = Adults with acute diarrhea (<4 weeks)}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01=<div style="float: left; text-align: left; line-height: 150% "> '''Obtain a brief history:''' | ||
---- | |||
❑ Onset <br> ❑ Duration <br> ❑ Pattern (Continuous or intermittent) <br> ❑ Type (Watery, bloody or fatty) <br> ❑ Fever <br> ❑ Abdominal pain <br> ❑ Nausea and vomiting <br> ❑ Weight loss <br> ❑ Epidemiological factors (Travel H/O, dietary H/O, outbreaks, seasons, institutionalization or sexual H/O) <br> ❑ Previous evaluations (Medications, radiation therapy or surgery) <br> ❑ Underlying medical condition (Cancer, diabetes, hyperthyroidism or other conditions) | |||
---- | |||
''' Examine the patient | |||
---- | |||
❑ General condition <br> | |||
❑ Level of consciousness <br> | |||
❑ Ability to drink <br> | |||
❑ Pulse <br> | |||
❑ Blood pressure <br> | |||
❑ Respiratory rate <br> | |||
❑ Eyes <br> | |||
❑ Skin turgor <br> | |||
❑ Mucosa</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = [[Acute diarrhea resident survival guide#Evaluation of Volume Status by Dhaka Method|Assessment of volume status]] }} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | C01 | | | C01 = [[Acute diarrhea resident survival guide#Evaluation of Volume Status by Dhaka Method|Assessment of volume status]] }} | ||
Line 35: | Line 49: | ||
{{familytree | | | | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | | | | | | | | | | | D03 | D01 = No dehydration | D02 = Some dehydration | D03 = Severe dehyration}} | {{familytree | | | | | | | | | D01 | | | | | | | | | | | | | | D02 | | | | | | | | | | | | | | D03 | D01 = No dehydration | D02 = Some dehydration | D03 = Severe dehyration}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | | | | | | | | | E01 | | | | | | | | | | | | | | E02 | | | | | | | | | | | | | | E03 | E01 = | {{familytree | | | | | | | | | E01 | | | | | | | | | | | | | | E02 | | | | | | | | | | | | | | E03 | E01 = <div style="float: left; text-align: left; line-height: 150% "> '''Start altered diet:''' | ||
---- | |||
❑ Stop lactose products <br> ❑ Avoid alcohol and high osmolar supplements <br> ❑ Drink 8-10 large glasses of clear fluids (Fruit juices, soft drinks etc) <br> ❑ Eat frequent small meals (Rice, potato, banana, pastas etc) <br> | |||
---- | |||
Can start [[oral rehydration therapy]] (ORT) for replacement of stool losses </div> | E02 = ❑ Start ORT at a volume of 50-100 mL/kg <br> ❑ Start altered diet <br> ❑ Reassess status every 4 hr | E03 = ❑ Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline <br> ❑ [[CBC]]<br> ❑ [[Electrolytes]] <br> ❑ Assess status every 15 mins until strong pulse felt and then every 1 hr <br> }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | E03 | | E03 = Patient stable and able to drink}} | |||
{{familytree | | | | | | | | | |`|-|-|-|-|-|-|-|v|-|-|-|-|-|-|-|'| | | | | | | | | | | | | | | |!| |}} | {{familytree | | | | | | | | | |`|-|-|-|-|-|-|-|v|-|-|-|-|-|-|-|'| | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | | | | | | | | | | | | | | | | | F01 | | | | | | | | | | | | | | | | | | | | | | | {{familytree | | | | | | | | | | | | | | | | | F01 | | | | | | | | | | | | | | | | | | | | | | F03 | F01 = <div style="float: left; text-align: left; line-height: 150% "> '''Check for the following warning signs:''' | ||
---- | |||
❑ Temperature ≥38.5ºC (101.3ºF) <br> ❑ Severe abdominal pain <br> ❑ Bloody diarrhea <br> ❑ Passage of ≥6 unformed stools per 24 hours <br> ❑ Acute presentation of persistent diarrhea <br> ❑ Diarrhea in the elderly (≥70 years of age) <br> ❑ Immunocompromised <br> ❑ Hospital-acquired <br> | |||
</div> | F03 = ❑ Start ORT at a volume of 100 mL/kg over 4 hour <br> ❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy ❑ Reassess status every 4 hr}} | |||
{{familytree | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | | | | | | | | | |!| |}} | {{familytree | | | | | | | | | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | | | | | | | | | G01 | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | |!| | G01 = NO | G02 = YES}} | {{familytree | | | | | | | | | G01 | | | | | | | | | | | | | | G02 | | | | | | | | | | | | | | |!| | G01 = NO | G02 = YES}} | ||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | | | | | | | | | H01 | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | H01 = | {{familytree | | | | | | | | | H01 | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | H01 = <div style="float: left; text-align: left; line-height: 150% "> '''Anti-motility drugs:''' | ||
---- | |||
❑ [[Loperamide]]: Two tablets (4 mg) initially, then 2 mg after each unformed stool OR <br> ❑ [[Bismuth subsalicylate]], 30 mL or two tablets every 30 minutes for eight doses <br> </div>}} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |)|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|'| |}} | {{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | |)|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|'| |}} | ||
{{familytree | | | | | | | | | I01 | | | | | | | | | | | | | | |!| | I01 = Assess the pt in 24 hrs}} | {{familytree | | | | | | | | | I01 | | | | | | | | | | | | | | |!| | I01 = Assess the pt in 24 hrs}} | ||
{{familytree | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | |!| |}} | {{familytree | |,|-|-|-|-|-|-|-|^|-|-|-|-|-|-|-|.| | | | | | | |!| |}} | ||
{{familytree | J01 | | | | | | | | | | | | | | J02 |-|-|-|-|-| | {{familytree | J01 | | | | | | | | | | | | | | J02 |-|-|-|-|-|-|!| | J01 = Resolved | J02 = Unresolved}} | ||
{{familytree | |!| | | | | | | | | | | | | | | | | | | | | | | |!| |}} | {{familytree | |!| | | | | | | | | | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | K01 | | | | | | | | | | | | | | | | | | | | | | K02 | K01 = Gradually add solid foods to diet | K02 = [[CBC]] | {{familytree | K01 | | | | | | | | | | | | | | | | | | | | | | K02 | K01 = Gradually add solid foods to diet | K02 = <div style="float: left; text-align: left; line-height: 150% "> '''Order investigations:''' | ||
---- | |||
❑ [[CBC]] <br> | |||
❑ [[Serum electrolytes]] <br> | |||
❑ [[Urinalysis ]] <br> | |||
❑ [[BUN]] <br> | |||
❑ [[Creatinine]] <br> | |||
❑ [[Fecal occult blood|Fecal occult blood (OBT)]]<br> | |||
❑ fecal WBC <br> | |||
</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | |!| |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | K03 |-|-|-|-|-|K04|-|-|-| K05 |K03 = [[Anemia]], [[thrombocytopenia]], elevated [[BUN]] and [[creatinine]] | K04 = YES | K05 = [[EHEC|E. coli O157:H7 suspicion]], stool culture and ELISA for Shiga toxin and [[Hemolytic-uremic syndrome medical therapy|supportive care]]}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | K03 |-|-|-|-|-|K04|-|-|-| K05 |K03 = [[Anemia]], [[thrombocytopenia]], elevated [[BUN]] and [[creatinine]] | K04 = YES | K05 = [[EHEC|E. coli O157:H7 suspicion]], stool culture and ELISA for Shiga toxin and [[Hemolytic-uremic syndrome medical therapy|supportive care]]}} | ||
Line 57: | Line 91: | ||
{{familytree | | | | | | | | | | | | | | | | | M01 | | | | | | | | | | | | | | M02 | | M01 = Non-inflammatory | M02 = Inflammatory}} | {{familytree | | | | | | | | | | | | | | | | | M01 | | | | | | | | | | | | | | M02 | | M01 = Non-inflammatory | M02 = Inflammatory}} | ||
{{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | |}} | {{familytree | | | | | | | | | | | | | | | | | |!| | | | | | | | | | | | | | | |!| | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | | | | N02 | | N01 = Symptomatic Rx | N02 = | {{familytree | | | | | | | | | | | | | | | | | N01 | | | | | | | | | | | | | | N02 | | N01 = Symptomatic Rx | N02 = Any recent antibiotic useage}} | ||
{{familytree | | | | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| |}} | {{familytree | | | | | | | | | | | | |,|-|-|-|-|^|-|-|-|-|.| | | | | |,|-|-|-|-|^|-|-|-|-|.| |}} | ||
{{familytree | | | | | | | | | | | | O01 | | | | | | | | O02 | | | | O03 | | | | | | | | O04 | O01 = Resolved | O02 = Unresolved | O03 = NO | O04 = YES}} | {{familytree | | | | | | | | | | | | O01 | | | | | | | | O02 | | | | O03 | | | | | | | | O04 | O01 = Resolved | O02 = Unresolved | O03 = NO | O04 = YES}} | ||
Line 63: | Line 97: | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| | | | | P01 | | | | | P02 | P01 = Negative [[clostridium difficile|C-diff]] | P02 = Positive [[clostridium difficile|C-diff]]}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |!| | | | | P01 | | | | | P02 | P01 = Negative [[clostridium difficile|C-diff]] | P02 = Positive [[clostridium difficile|C-diff]]}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | | | | | |!| |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | | | | | |!| |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R01 | | | | | | | | R02 | R01 = [[Stool culture | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R01 | | | | | | | | R02 | R01 = [[Stool culture]] | R02 = [[Clostridium difficile medical therapy|Metronidazole/Vancomycin]]}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | |!| | | | | | | | | | | |}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | | | | R03 | | | | | | | | | | | R03 = <div style="float: left; text-align: left; line-height: 150% "> '''Emperical antibiotic trial:''' | |||
---- | |||
❑ Oral [[ciprofloxacin]] 500 mg BD X 3-5 days OR<br> ❑ Oral [[levofloxacin]] 500 mg OD X 3-5 days OR<br> ❑ Oral [[norfloxacin]] 400 mg BD X 3-5 days OR<br> ❑ Oral azithromycin 500 mg OD X 3 days OR<br> ❑ erythromycin 500 mg BD X 5 days <br> | |||
</div>}} | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |,|-|-|^|-|-|.| | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |,|-|-|^|-|-|.| | |}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | S01 | | | | S02 | | S01 = Negative culture | S02 = Positive culture}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | S01 | | | | S02 | | S01 = Negative culture | S02 = Positive culture}} | ||
Line 71: | Line 110: | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | U01 | | | | U02 | | | | |!| | | | U01 = Negative | U02 = Positive}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | U01 | | | | U02 | | | | |!| | | | U01 = Negative | U02 = Positive}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | }} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | | | | |`|-|-|v|-|-|'| | }} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | V01 | | | | | | | V02 | | | V01 = Consider imaging/scope | V02 = [[Acute diarrhea resident survival guide#Specific Antibiotics| | {{familytree | | | | | | | | | | | | | | | | | | | | | | V01 | | | | | | | V02 | | | V01 = Consider imaging/scope | V02 = [[Acute diarrhea resident survival guide#Specific Antibiotics|Specific antibiotics as per results]]}} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | }} | {{familytree | | | | | | | | | | | | | | | | | | | | | | |!| | }} | ||
{{familytree | | | | | | | | | | | | | | | | | | | | | | V03 | V03 = Rule out [[IBD]], [[colon cancer]], [[diverticulitis]], [[appendicitis]] etc.}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | V03 | V03 = Rule out [[IBD]], [[colon cancer]], [[diverticulitis]], [[appendicitis]] etc.}} | ||
{{familytree/end}} | {{familytree/end}} | ||
===Evaluation of Volume Status by Dhaka Method=== | ===Evaluation of Volume Status by Dhaka Method=== | ||
Line 103: | Line 137: | ||
† Some dehydration = At least two signs, including at least one key sign (*) are present. <BR> | † Some dehydration = At least two signs, including at least one key sign (*) are present. <BR> | ||
‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present. | ‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present. | ||
===Oral Rehydration Therapy=== | ===Oral Rehydration Therapy=== | ||
Line 117: | Line 146: | ||
* Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg. | * Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg. | ||
* Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT. A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours. Additional ORS is given to replace ongoing loss of stool. At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour. | * Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT. A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours. Additional ORS is given to replace ongoing loss of stool. At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour. | ||
===Specific Antibiotics=== | ===Specific Antibiotics=== | ||
Line 154: | Line 158: | ||
* For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics. | * For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics. | ||
* Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management. | * Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management. | ||
* When using normal saline due to unavailability of ringer lactate in diarrhea patients, ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses. | * When using normal saline due to unavailability of ringer lactate in diarrhea patients, [[oral rehydration therapy]] ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses. | ||
* A nasogastric tube can be used to deliver ORT in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. | |||
* Always check for warning signs before initiating anti-motility drugs. | |||
* Use [[bismuth subsalicylate]] for symptomatic treatment of acute diarrhea with significant fever and dysentery, where loperamide is contraindicated. | |||
* Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics. | * Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics. | ||
* Report to the public health authorities in case of suspected outbreaks. | * Report to the public health authorities in case of suspected outbreaks. | ||
Line 161: | Line 168: | ||
* Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death. | * Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death. | ||
* ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush. | * ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush. | ||
* Loperamide should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea. | * [[Loperamide]] should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea. | ||
* Dont use [[diphenoxylate]], as it has central opiate effects and may cause cholinergic side effects. In addition, patients should be cautioned that treatment with these agents may mask the amount of fluid lost, since fluid may pool in the intestine. | |||
==References== | ==References== |
Revision as of 17:19, 31 December 2013
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Definition
Three or more bowel movements daily are considered to be abnormal, and the upper limit of stool weight is generally agreed to be 200 g daily.[1] Acute diarrhea has a duration of less than four weeks. Most cases of acute diarrhea are due to infections with viruses and bacteria and are self-limited. The evaluation of patients for a noninfectious etiology should be considered as the course of diarrhea persists and becomes chronic.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
Common Causes
Inflammatory Causes
- Bacterial : Campylobacter, Clostridium difficile, E. coli (O157:H7), Salmonella typhi, Salmonella(nontyphoidal), Shigella, Vibrio parahaemolyticus
- Viral : Cytomegalovirus
- Parasitic : Entamoeba histolytica
Noninflammatory Causes
- Bacterial : E.coli (toxigenic), Vibrio cholerae
- Viral : Rotavirus, Norovirus
- Parasitic : Giardia, Cryptosporidium, Cyclospora
- Performed toxin : Staphylococcus aureus, Bacillus cereus, Clostridium perfringens
Management
Adults with acute diarrhea (<4 weeks) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obtain a brief history:
❑ Onset Examine the patient ❑ General condition | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assessment of volume status | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No dehydration | Some dehydration | Severe dehyration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Start altered diet:
❑ Stop lactose products Can start oral rehydration therapy (ORT) for replacement of stool losses | ❑ Start ORT at a volume of 50-100 mL/kg ❑ Start altered diet ❑ Reassess status every 4 hr | ❑ Start IV fluids: Ringer lactate at 30ml/kg in the first 1/2hr and 70ml/kg for the next 2 1/2 hr, if unavailable use normal saline ❑ CBC ❑ Electrolytes ❑ Assess status every 15 mins until strong pulse felt and then every 1 hr | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Patient stable and able to drink | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check for the following warning signs:
❑ Temperature ≥38.5ºC (101.3ºF) | ❑ Start ORT at a volume of 100 mL/kg over 4 hour ❑ Calculate the continuing stool and emesis losses every hour for additional maintenance ORT therapy ❑ Reassess status every 4 hr | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NO | YES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-motility drugs:
❑ Loperamide: Two tablets (4 mg) initially, then 2 mg after each unformed stool OR ❑ Bismuth subsalicylate, 30 mL or two tablets every 30 minutes for eight doses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assess the pt in 24 hrs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Resolved | Unresolved | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gradually add solid foods to diet | Order investigations:
❑ CBC | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anemia, thrombocytopenia, elevated BUN and creatinine | YES | E. coli O157:H7 suspicion, stool culture and ELISA for Shiga toxin and supportive care | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative fecal WBC/OBT | Positive fecal WBC/OBT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Non-inflammatory | Inflammatory | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symptomatic Rx | Any recent antibiotic useage | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Resolved | Unresolved | NO | YES | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative C-diff | Positive C-diff | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Stool culture | Metronidazole/Vancomycin | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Emperical antibiotic trial:
❑ Oral ciprofloxacin 500 mg BD X 3-5 days OR | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative culture | Positive culture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Check ova and parasites | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Negative | Positive | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider imaging/scope | Specific antibiotics as per results | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rule out IBD, colon cancer, diverticulitis, appendicitis etc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Evaluation of Volume Status by Dhaka Method
Assessment | No dehydration | Some dehydration† | Severe dehydration‡ |
General condition | Normal | Irritable/less active* | Lethargic/comatose§ |
Eyes | Normal | Sunken | — |
Mucosa | Normal | Dry | — |
Thirst | Normal | Thirsty | Unable to drink§ |
Radial pulse | Normal | Low volume* | Absent/ uncountable§ |
Skin turgor | Normal | Reduced | — |
† Some dehydration = At least two signs, including at least one key sign (*) are present.
‡ Severe dehydration = Signs of “some dehydration” plus at least one key sign (§) are present.
Oral Rehydration Therapy
For each degree of dehydration, treatment is divided into two phases:
- Rehydration phase : Water and electrolytes are administered to replace losses. The fluid deficit is replaced quickly over three to four hours, returning the patient to a euvolemic state.
- Maintenance phase : Maintenance fluid therapy to take care of ongoing losses once rehydration is achieved (along with appropriate nutrition).
- No dehydration : ORT is used to maintain hydration by replacement of stool losses.
- Some dehydration : Hydration should be restored by administering ORT at a volume of 50-100 mL/kg.
- Severe dehydration : As the patient's clinical condition stabilizes and his/her level of consciousness returns to normal, therapy can be changed to ORT. A nasogastric tube can be used in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid. The intravenous line should remain in place until it is certain there is successful transition to ORT. ORT therapy is started at a volume of 100 mL/kg over 4 hours. Additional ORS is given to replace ongoing loss of stool. At the end of each hour, the patient's hydration status and continuing stool and emesis losses should be calculated, with the total hourly loss added to the amount to be given over the next hour.
Specific Antibiotics
- Salmonella : Oral ciprofloxacin 500 mg BD or levofloxacin 500 mg OD / oral trimethoprim-sulfamethoxazole 160 mg/800 mg BD / oral amoxicillin 500 mg TID / if intravenous therapy is required, ceftriaxone 1 to 2 g OD or cefotaxime 2 g intravenously TID.
- Vibrio cholera : Oral ciprofloxacin 500mg BD X 3 days / doxycycline 300mg OD single doze / azithromycin 1g OD single doze / tetracycline 500 mg QID X 3 days.
- Shigellosis : Oral ciprofloxacin 500mg BD X 3 days / oral pivmecillinam 400mg TID or QID X 5 days / IV ceftriaxone 2-4g as OD.
- Campylobacter : Oral Azithromycin 500 mg OD X 3 days / Oral ciprofloxacin 500mg BD X 3 days.
- Giardiasis : Metronidazole 250 mg TID for 5 days / tinidazole OD 50 mg/kg orally to a maximum dose of 2 g / ornidazole 2 g OD as single doze.
- Amebiasis : Metronidazole 750 mg TID for 5 days.
Do's
- For acute diarrhea, maintaining adequate intravascular volume and correcting fluid and electrolyte disturbances take priority over identifying the causative agent from detailed history and clinical findings, including stool characteristics.
- Assess ABCD periodically depending on the patient status and check for any warning signs during the course of management.
- When using normal saline due to unavailability of ringer lactate in diarrhea patients, oral rehydration therapy ORT should be initiated as soon as they are able to drink, to replace bicarbonate and potassium losses.
- A nasogastric tube can be used to deliver ORT in patients who have a normal mental status but may be too weak to adequately drink the necessary volume of fluid.
- Always check for warning signs before initiating anti-motility drugs.
- Use bismuth subsalicylate for symptomatic treatment of acute diarrhea with significant fever and dysentery, where loperamide is contraindicated.
- Stool cultures are usually unnecessary for immune-competent patients who present with watery diarrhea, but may be necessary when there is clinical and/or epidemiological suspicion of a causative agent, particularly during the early days of outbreaks/epidemics.
- Report to the public health authorities in case of suspected outbreaks.
Don'ts
- Don't treat patients with severe diarrheal dehydration using 5% dextrose with 1/4 normal saline, as using solutions with lower amounts of sodium (such as 38.5 mmol/L in 1/4 saline with 5% dextrose ) would lead to sudden and severe hyponatremia with a high risk of death.
- ORT is contraindicated in the initial management of severe dehydration and also in patients with frequent and persistent vomiting (more than four episodes per hour), and painful oral conditions such as moderate to severe thrush.
- Loperamide should be avoided in patients with significant abdominal pain, fever and bloody diarrhea that suggests inflammatory diarrhea.
- Dont use diphenoxylate, as it has central opiate effects and may cause cholinergic side effects. In addition, patients should be cautioned that treatment with these agents may mask the amount of fluid lost, since fluid may pool in the intestine.
References
- ↑ Sleisenger, Marvin H.; Feldman, Mark; Friedman, Lawrence S. (Lawrence Samuel); Brandt, Lawrence J. (2010). Sleisenger and Fordtran's gastrointestinal and liver disease : pathophysiology, diagnosis, managemen. Philadelphia , PA: Saunders/Elsevier. ISBN 1-4160-6189-4.